Journal Home
Search for

Volume 35, Issue 8, Pages 1265-1270 (August 2009)


View previous. 8 of 22 View next.

Accuracy of Stent Measurements Using ECG-Gated Greyscale Intravascular Ultrasound Images: A Validation Study

Ryan K. Kaple, Kenichi Tsujita, Akiko Maehara, Gary S. MintzCorresponding Author Informationemail addressemail address

Received 26 August 2008; received in revised form 3 February 2009; accepted 13 February 2009. published online 22 June 2009.

Abstract 

Greyscale intravascular ultrasound (IVUS) is an accurate tool for measuring stent dimensions and residual disease at the stent edge. Electrocardiographically (ECG)-gated IVUS is used in evolving second-generation IVUS systems, but this modality provides fewer greyscale cross-sectional images, and its accuracy to measure stent dimensions has not been assessed. This study was designed to validate the use of ECG-gated greyscale IVUS in measuring minimum stent area (MSA), stent length and reference dimensions compared to standard greyscale IVUS data. IVUS imaging was performed after drug-eluting stent implantation in 53 target lesions in 48 patients with acute coronary syndrome. The IVUS catheter was mechanically withdrawn at 0.5 mm/s, standard greyscale images were collected at 10 frames/s, and ECG-gated greyscale images were constructed from R-wave gated images. The MSA measured 6.20 ± 1.75 mm2 vs. 5.98 ± 1.55 mm2 on standard greyscale and ECG-gated greyscale IVUS, respectively (R2 = 0.91, p = 0.005). The MSA position (R2 = 0.66, p = 0.179) and stent length (R2 = 0.99, p = 0.435) measurements were similar between modalities. Proximal reference vessel area was larger by ECG-gated IVUS, but proximal reference lumen and distal reference measurements were similar. Bland-Altman plots demonstrated good agreement between modalities. In conclusion, ECG-gated greyscale IVUS provides accurate and reliable measurements of stent length, area and reference segment plaque burden after stent implantation and is not inferior to standard greyscale IVUS. (E-mail: gsm18439@aol.com or gmintz@crf.org).

The Cardiovascular Research Foundation, Columbia University Medical Center, New York City, NY

Corresponding Author InformationAddress correspondence to: Gary S. Mintz, M.D., Cardiovascular Research Foundation, 611 Pennsylvania Ave, SE #386, Washington, DC 20003.

 Disclosures: GS Mintz is a consultant for the Volcano Corporation.

PII: S0301-5629(09)00073-8

doi:10.1016/j.ultrasmedbio.2009.02.003


View previous. 8 of 22 View next.